JPMorgan Chase & Co. Has $79,000 Stock Position in GoHealth, Inc. (NASDAQ:GOCO)

JPMorgan Chase & Co. increased its stake in shares of GoHealth, Inc. (NASDAQ:GOCO) by 99.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,437 shares of the company’s stock after purchasing an additional 4,204 shares during the quarter. JPMorgan Chase & Co.’s holdings in GoHealth were worth $79,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of GOCO. Barclays PLC boosted its holdings in shares of GoHealth by 83.9% during the 3rd quarter. Barclays PLC now owns 9,580 shares of the company’s stock worth $89,000 after buying an additional 4,372 shares during the period. Renaissance Technologies LLC raised its stake in shares of GoHealth by 22.0% in the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock valued at $178,000 after purchasing an additional 3,300 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of GoHealth by 5.1% during the 3rd quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock worth $207,000 after acquiring an additional 1,072 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of GoHealth by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock valued at $973,000 after purchasing an additional 3,205 shares during the period. 24.21% of the stock is currently owned by hedge funds and other institutional investors.

GoHealth Stock Down 0.2 %

Shares of NASDAQ GOCO opened at $16.26 on Tuesday. GoHealth, Inc. has a 52-week low of $7.27 and a 52-week high of $18.20. The stock has a market cap of $372.45 million, a P/E ratio of -4.65 and a beta of 1.64. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. The firm has a 50 day moving average price of $13.43 and a 200 day moving average price of $11.42.

GoHealth (NASDAQ:GOCO) last announced its earnings results on Thursday, November 7th. The company reported ($3.73) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.19) by ($0.54). The firm had revenue of $118.29 million for the quarter, compared to the consensus estimate of $105.93 million. GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. During the same quarter last year, the business posted ($2.61) EPS. Analysts expect that GoHealth, Inc. will post -5.5 EPS for the current year.

Analyst Ratings Changes

Separately, Royal Bank of Canada reissued a “sector perform” rating and issued a $13.00 price objective on shares of GoHealth in a research note on Monday, October 21st.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.